Patent ID: 11938106
Assignee: NORTHEAST OHIO MEDICAL UNIVERSITY
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 1:
2. The method of claim 1, wherein the group II mGluR agonist is selected from the group consisting of (1S,3R)-ACPD, cis-ACPD, (±)-trans-ACPD, (2R,4R)-APDC, (S)-3-Carboxy-4-hydroxyphenylglycine, (S)-4-Carboxy-3-hydroxyphenylglycine, (S)-4-Carboxyphenyglycine, L-CCG-I, DCG IV, LY354740, LY379268, (±)-LY395756, MAP4, NPEC-caged-LY379268, and spaglumic acid, and pharmaceutically acceptable salts thereof.